Corporate ActionSep 22, 2026, 04:34 PM
Alaunos Therapeutics Prices Registered Direct Offering
AI Summary
Alaunos Therapeutics, Inc. announced the pricing of a registered direct offering, selling 380,469 shares of common stock and 386,654 pre-funded warrants at $1.46 and $1.459 per share/warrant, respectively. The offering, which closed on September 21, 2026, generated approximately $0.915 million in net proceeds intended for general corporate purposes and working capital. Dawson James Securities, Inc. served as the exclusive placement agent, and company officers and directors agreed to a 15-day lock-up period.
Key Highlights
- Alaunos Therapeutics priced a registered direct offering of 380,469 shares of common stock and 386,654 pre-funded warrants.
- The offering was priced at $1.46 per share and $1.459 per pre-funded warrant.
- The company raised approximately $0.915 million in net proceeds after offering expenses.
- Net proceeds are intended for general corporate purposes, including working capital.
- Officers and directors entered into 15-day lock-up agreements in connection with the offering.
- Dawson James Securities, Inc. acted as the exclusive placement agent for the offering.
Price Impact
More from TCRT